PTC Therapeutics Inc PTCT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
34.16UNCH (UNCH)
Volume
27,733
Close
34.16quote price arrow up+2.01 (+6.25%)
Volume
1,067,358
52 week range
17.53 - 59.84
Loading...
  • Open32.31
  • Day High35.47
  • Day Low31.70
  • Prev Close32.15
  • 52 Week High59.84
  • 52 Week High Date05/22/23
  • 52 Week Low17.53
  • 52 Week Low Date11/02/23

Key Stats

  • Market Cap2.62B
  • Shares Out76.70M
  • 10 Day Average Volume1.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.63
  • YTD % Change23.95

KEY STATS

  • Open32.31
  • Day High35.47
  • Day Low31.70
  • Prev Close32.15
  • 52 Week High59.84
  • 52 Week High Date05/22/23
  • 52 Week Low17.53
  • 52 Week Low Date11/02/23
  • Market Cap2.62B
  • Shares Out76.70M
  • 10 Day Average Volume1.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.63
  • YTD % Change23.95

RATIOS/PROFITABILITY

  • EPS (TTM)-7.69
  • P/E (TTM)-4.44
  • Fwd P/E (NTM)-5.73
  • EBITDA (TTM)132.42M
  • ROE (TTM)-7,740.12%
  • Revenue (TTM)927.558M
  • Gross Margin (TTM)92.88%
  • Net Margin (TTM)-62.45%
  • Debt To Equity (MRQ)-239.50%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On PTC Therapeutics Inc

 

Profile

MORE
PTC Therapeutics, Inc. is a global biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The Company has a diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments...
Michael Schmertzler
Independent Chairman of the Board
Matthew Klein M.D.
President, Chief Executive Officer, Director
Neil Almstead Ph.D.
Chief Technical Operations Officer
Pierre Gravier
Chief Financial Officer
Mark Boulding
Executive Vice President, Chief Legal Officer
Address
500 Warren Corporate Center Drive
Warren, NJ
07059
United States

Top Peers

SYMBOLLASTCHG%CHG
GLPG
Galapagos NV
29.34+0.89+3.13%
MYGN
Myriad Genetics Inc
19.47-0.10-0.51%
ACAD
ACADIA Pharmaceuticals Inc
17.05+0.34+2.03%
GH
Guardant Health Inc
18.26+0.26+1.44%
NVAX
Novavax Inc
4.67+0.34+7.85%